OMCL Add to watchlist
$35.39 +0.00 (+0.00%)
Pre-Market: $35.39 +0.00 (+0.00%)
Last updated: Oct 15, 2026 09:32
52-Week Range
$35.39
$29.09 $35.39 $55.00

Fundamentals Overview

Omnicell Inc is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 41.6 PEG 1.39 P/B 1.46 P/S 1.3

Profitability

ROE 3.13% Net margin 3.1%

Risk (Beta)

0.92 — in line vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 59% confidence Risk: Moderate Volatility — Beta 0.92. Diversify and only invest what you can afford to lose.

Pressures (Sell):

P/E 41.6 (premium)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$1.61B
P/E (TTM)
41.58
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$29.09 - $55.00
Volume vs Avg
N/A
Beta
0.92

About

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority o...
Sector: Healthcare
Headquarters: US
Beta: 0.92 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric Value
Valuation
P/E (TTM) 41.58
PEG (TTM) 1.39
P/B (TTM) 1.46
P/S (TTM) 1.3
Profitability
ROE (TTM) 3.13%
ROA (TTM) 1.97%
Revenue growth (YoY) N/A
Net margin (TTM) 3.13%
Gross margin (TTM) 44.77%
Operating margin (TTM) 4.65%
Debt to equity (TTM) 0.13

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for OMCL.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.